Vicente Arrate and his team from the University of Elche conducted a prospective observational cohort study. They found that women who experienced premature or early menopause have a significantly increased probability of developing arterial hypertension.
Data from nearly 108 thousand women in the UK Biobank repository, covering the period from 2006 to 2023, were used for the analysis. Premature menopause was defined as the onset of menstruation before the age of 40, while early menopause was recorded between the ages of 40 and 45. The link between these conditions and hypertension was assessed using Weibull distribution survival models, taking into account adjustments for lifestyle, presence of comorbidities, and laboratory test results. The average follow-up duration in this study was 14.5 years.
During the observation period, arterial hypertension developed in 17.2 percent of participants. An increase in the cumulative incidence of the disease was identified as the age of menopause onset decreased: it was 16.6 percent for normal timing, 18.8 percent for early menopause, and 22.6 percent for premature menopause (which is statistically significant, p < 0.001). Although the incidence of hypertension was higher in women after surgical menopause, this effect disappeared when using multivariate models. Nevertheless, the association with premature menopause persisted, demonstrating a 12.3 percent increase in the risk of developing hypertension.
Previously, American scientists had already noted a correlation between premature menopause and a higher overall risk of cardiovascular diseases.
In another study, Elizabeth Jane Phillips and her colleagues from Canada conducted a systematic review and meta-analysis of scientific publications. Their analysis showed that anticonvulsants can cause almost a quarter of severe skin reactions—Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome)—which are associated with high mortality. The researchers searched databases MEDLINE and Embase up to March 2026, including 50 publications involving 4403 patients in the review. This data was combined using a mixed-effects meta-analysis, and the results were published in the journal JAMA Dermatology.
The United Arab Emirates (UAE) has become the second country in the world to authorize a new once-daily oral medication for adults with elevated levels of 'bad' cholesterol. This drug was approved after the US.
The Emirates Drug Authority (EDA) approved the drug Lipfendra, which contains the active ingredient enlicitide. It is intended for adults with high levels of low-density lipoprotein cholesterol, known as LDL-C.
Furthermore, this medication may be prescribed to some patients with hereditary conditions causing high cholesterol. However, the decision to treat must be made by a medical specialist after a thorough assessment of the patient's condition.
Lipfendra is taken once a day and should be used as part of a comprehensive treatment plan that necessarily includes a balanced diet and regular physical activity. LDL is often called 'bad cholesterol' because high levels increase the risk of cardiovascular diseases.
The new medication is designed to help adults lower their LDL levels who require additional treatment alongside lifestyle changes. This approval provides doctors with another therapeutic option for patients whose cholesterol levels require further medical intervention.
The EDA stated that this decision also supports efforts to improve the quality of pharmaceutical care in the country. Moreover, the EDA emphasized that the latest approval demonstrates the effectiveness of the UAE's regulatory system and its commitment to providing patients with faster access to innovative medicines.
However, the authority strongly warned that medications should not replace a healthy lifestyle. People with high cholesterol were advised to maintain a balanced diet, stay physically active, and consult a doctor before starting any treatment.
A healthcare professional is obliged to assess the patient's cholesterol level, medical history, and other risk factors before deciding if this drug is suitable. The EDA also urged individuals with high cholesterol to take steps to reduce the risk of cardiovascular diseases and improve overall health through both medical care and lifestyle changes.
According to the National Institute of Health Management, more than 600 migrants were assisted in hospitals and health centers in the city of Ceuta. Of this total, 12 individuals required hospitalization, one of whom was in intensive care and two others in the neonatology service, dedicated to newborns.
Overall, the four medical teams of the 061 emergency service attended 198 people. Specifically, the hospital's emergency department received 187 patients over the two days, while the Otero health center provided assistance to 76 people from Morocco, making these the three locations with the highest volume of care.
No deaths were recorded in these care centers. However, on the same day, police sources reported that the number of bodies recovered off the coast of Ceuta reached 67.
The same police source indicated that the routine of health and hospital services in the city was not affected by the recent migratory movement, which involved thousands of people entering the city without following legal procedures.
The Civil Guard maintains search operations near the Tarajal border pier, where all the bodies were found at sea. With these victims, the number of migrants who have died this year while trying to reach Ceuta by swimming rises to 92.
Security forces and emergency services are tracking the location of bodies of people who jumped into the sea from the Moroccan coasts of Castillejos, in an attempt to reach the coast of Ceuta by swimming. Authorities acknowledge the possibility that the death toll may continue to rise.
A major news event occurred in Chhatrapati Sambhajinagar, Maharashtra state: the health of Abhijit Dipke, founder of the Kokrut Janta Party, suddenly deteriorated. He went out of his house to interact with the media, but at that moment, he began to vomit, and his condition sharply worsened.
Afterward, he returned home without managing to give any comments to anyone. Doctors are currently at his home conducting an examination to determine the cause of the sudden decline in his health.
The incident took place in Chhatrapati Sambhajinagar, where Abhijit Dipke was scheduled to meet journalists near his residence. Since he regularly interacted with the press, people were expecting his statements. However, as soon as he came down from his house, his health began to rapidly decline, and he complained of vomiting, which surprised those present.
Following the deterioration of his condition, Abhijit Dipke declined to engage with the media and headed straight back home. His supporters and family members immediately called for doctors. Medics are now at his home conducting a thorough check of his health to establish the primary reason for the sharp drop in well-being.
At this time, there is no specific information regarding what exactly caused his health deterioration. The situation concerning his condition will only become clear after the completion of the medical examination. It should be noted that he recently suffered from typhoid during demonstrations at Jantar Mantar in Delhi.
An atmosphere of concern prevails among his supporters, and all attention is focused on the results of the medical assessment. Additional information about his health status will become available once the examination is complete.
